ACD/Labs, Virscidian: High-Throughput Analysis at ASMS 2023
ACD/Labs and Virscidian collaborate to enhance high-throughput analysis, leveraging decades of experience for improved productivity and scientific outcomes.
ACD/Labs and Virscidian Announce a Collaboration to Support High Throughput Analysis Workflows, at ASMS 2023
ACD/Labs, an informatics company that develops and commercializes software in support of R&D, and Virscidian, a provider of analytical informatics and processing software, today announced a collaboration to support better mutual customers undertaking high throughput analyses. The partners independently bring decades of experience and expertise in vendor-neutral solutions for analytical data processing and management.
“It’s vital that scientists can choose instruments and technologies to increase productivity without compromising scientific rigor,” says Graham McGibbon, Director of Strategic Partnerships at ACD/Labs”. “Every vendor—of both hardware and software—delivers particular capabilities of interest to users. With decades-long vibrant and active partner relationships, ACD/Labs has long been a proponent of integrating with the systems and technologies our customers choose. We’re excited to work with Virscidian and bring the best of our offerings to the challenges of high throughput data analysis.”
“We are excited to collaborate with ACD/Labs so that customers can increase productivity in their high throughput workflows.” said Joseph Simpkins, CEO, Virscidian. “This partnership will help drive better scientific outcomes more rapidly, deliver greater confidence in results, and allow results to be accessible where needed to enable research teams.”
Visit us in the exhibition at ASMS—ACD/Labs Booth 809— or contact us at [email protected] to discuss how we can support your HTE analysis workflows.
About ACD/Labs
ACD/Labs is a leading provider of scientific software for R&D. We help customers in >94 countries assemble digitized analytical, structural, and molecular information for effective decision-making, problem solving, and product lifecycle control. Our enterprise technologies enable automation of molecular characterization and facilitate chemically intelligent knowledge management.
ACD/Labs provides worldwide sales and support and brings decades of experience and success helping organizations innovate and create efficiencies in their workflows. For more information, please visit www.acdlabs.com. Follow us on Twitter and LinkedIn.
About Virscidian
Virscidian is a privately owned software company helping to accelerate Chromatographic and Mass Spectrometric Drug Discovery Workflows. Our mission is to transform chromatographic and mass spectrometric raw data into its digital form, thereby enabling automated results interpretation and actionable decisions rapidly, reliably, and robustly. Our software drives measurable efficiency and productivity gains in laboratories worldwide.
Virscidian’s production workflows span all stages of drug discovery, including synthetic reaction design and screening, purification, compound management screening, Affinity Selection Mass Spectrometry, and qualitative and quantitative MS-driven bio-assay screening. For more information, visit us at www.virscidian.com or contact us at [email protected]. Follow us on LinkedIn.
ACD/Labs Media Contact:
Sanji Bhal, ACD/Labs
(416) 368-3435
[email protected]
Virscidian Inc. Media Contact:
Joseph Simpkins
[email protected]